| Application no. and date | 07842842.2 (espacenet) (Federated) (European Patent Register), 20070920 | | Patent/reg. no. and date | DK/EP 2068938, 20110119 | | Publication date | 20090617 | | Priority no. and date | US 826622 P, 20060922, US 828278 P, 20061005 | | EP pub. no. and date |
EP 2068938 20090617 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 140843 | | Inventor | GATHMANN, Insa, Claragraben 115
CH-4057 Basel, CH,
MAHON, Francois-Xavier, 6, rue Condillac
F-33000 Bordeaux, FR,
MOLIMARD, Mathieu, University Victor Ségalen Bordeaux 2
Department of Clinical Pharmacology and Toxicolog
y;
146 rue Léo-Saignat
F-33076 Bordeaux, FR,
PICARD, Stéphane, University Victor Ségalen Bordeaux 2
Department of Clinical Pharmacology and Toxicolog
y;
146 rue Léo-Saignat
F-33076 Bordeaux, FR,
WANG, Yanfeng, 7 Kice Road
Florham Park, New Jersey 07932, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/506 (2006.01) , A61K 49/00 (2006.01) , A61P 35/02 (2006.01) | | Title | Optimering af behandlingen af Philadelphia-positiv leukæmi med ABL-tyrosinkinaseinhibitor imatinib | | Int. application no. | US2007078978 | | Int. publication no. | WO2008036792 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
